Real-world effectiveness of brentuximab vedotin vs other treatments in patients with relapsed/refractory hodgkin lymphoma post autologous stem-cell transplantation.
Zagadailov, E Corman, S Hagan, M Chirikov, V Johnson, C Macahilig, C Sea, B Dalal, M Brockelmann, P Illidge, Timothy M
Zagadailov, E
Corman, S
Hagan, M
Chirikov, V
Johnson, C
Macahilig, C
Sea, B
Dalal, M
Brockelmann, P
Illidge, Timothy M
Citations
Altmetric:
Abstract
Description
Date
2017-05-24
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Real-world effectiveness of brentuximab vedotin vs other treatments in patients with relapsed/refractory hodgkin lymphoma post autologous stem-cell transplantation. 2016, 101(s5): 51 Haematologica